Development of an effective meropenem/KPC-2 inhibitor combination to combat infections caused by carbapenem-resistant Klebsiella pneumoniae

Y Tang, C Yang, C Liu, Y Xu, M Peng… - International Journal of …, 2024 - Elsevier
The global public health threat of antibiotic resistance continues to escalate, and
necessitates the implementation of urgent measures to expand the arsenal of antimicrobial …

Synergistic antibacterial activity of ceftazidime–avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella …

NÜ Tüzemen, U Önal, O Merdan, B Akca, B Ener… - Scientific reports, 2024 - nature.com
Carbapenem-resistant Klebsiella pneumoniae (CPKP) infections seriously threaten global
public health. The main objective of this study was to assess the in-vitro synergistic activity of …